TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›BRZE
BRZE logo

BRZE

Braze, Inc.

Next earnings Sep 2, 2026 · consensus $0.15 EPS, $224M rev

Last earnings -3.4% on 2026-05-27

Buy
$23.81
▲ +13.54%
$23.81▼ -11.02%
over 1Y
L $16.93H $36.19
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+13.5%
1W+21.7%
1M-7.3%
3M+0.5%
YTD-26.9%
1Y-11.0%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
C-
Valuation
Fair value
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 27 analysts
Buy

Cheap at 3.2x sales while cash flow inflects hard — 24% grower whose GAAP losses mask a real FCF turn.

Revenue $738M (+24.4% YoY) · FY2026

Braze is a customer-engagement SaaS platform that is still compounding revenue at a healthy clip — $738M in FY2026, +24.4% YoY — across 2,609 customers, on a land-and-expand model where pricing scales with the customer's own messaging volume and MAUs. Gross margin is a solid 67.1%, and the balance sheet is unlevered (liabilities/equity 0.78x, $624M equity). The single most important shift in this filing is cash generation: operating cash flow nearly doubled to $71.4M (+94.8%), and management discloses non-GAAP free cash flow of $58.1M versus $19.6M a year ago and $(6.5)M two years ago — a clean three-year inflection from cash-burning to genuinely self-funding. At a $2.38B market cap, the stock trades at just 3.2x trailing sales, an unusually compressed multiple for a profitable-on-a-cash-basis, mid-20s grower.

The bear case is real and sits right on the income statement. GAAP losses have not gone away — net income was -$131M, actually worse than FY2025's -$104M, with an operating margin of -19.6% and ROE of -21.0%. The accumulated deficit stands at -$718M. Revenue growth is also decelerating: 24.4% this year versus 25.8% last year, and the company's own Risk Factors warn that 'rapid revenue growth may not be indicative of our future revenue growth' and that it has 'a history of operating losses and may not achieve or sustain profitability.' Cash on hand is thin at $124M, and the filing flags that it 'may require additional capital… [that] might not be available on acceptable terms.' The gap between the widening GAAP loss and the surging cash flow is almost certainly stock-based compensation and other non-cash items — which is shareholder dilution by another name, not a free lunch.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 12:02 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Is BRZE a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$238M$355M$472M$593M$738M
Gross profit$160M$240M$324M$410M$496M
Operating income-$78.2M-$148M-$145M-$122M-$145M
Net income-$76.7M-$139M-$129M-$104M-$131M
Diluted EPS-$2.20-$1.47-$1.32-$1.02-$1.22
Net margin-32.2%-39.1%-27.4%-17.5%-17.8%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.56B
EV / EBITDA—
EV / Sales3.5
EV / FCF41.3
P / FCF43.4
PEG (trailing)—
Earnings yield-4.9%
FCF yield2.3%

Quality & risk

ROIC (est.)-18.3%
Free cash flow$61.9M
Total debt—
Net cash$124M
Altman Z-Score2.78 grey
Piotroski F-Score3/7

Capital returns

Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Charter / bylaws change2026-07-02
  2. 10-Q Quarterly report2026-05-28

    Q1 FY27 10-Q: growth continues but operating losses persist

  3. 8-K Officer / director change2026-05-27

    Posted Q1 FY27 results and announced an executive leadership change

  4. DEF 14A Proxy statement2026-05-18

    2026 annual proxy: board, exec pay and say-on-pay up for vote

  5. 8-K Officer / director change2026-04-28

    Announced a leadership transition plus a Reg FD business update

  6. 8-K Officer / director change2026-04-07

    Disclosed an officer/director change

  7. 10-K Annual report2026-03-25

    FY26 10-K: revenue +24% to $738M, FCF positive, net loss widened to $131M

  8. 8-K Earnings results2026-03-24

    Q4/FY26 results: revenue +24% to $738M, free cash flow turned positive

  9. 8-K Material event2026-02-02

    Amended charter/bylaws modifying Class A shareholder rights

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗144Filing2026-06-26open ↗4Period ending 2026-06-242026-06-26open ↗4Period ending 2026-06-052026-06-09open ↗SCHEDULE 13GFiling2026-06-05open ↗4Period ending 2026-05-292026-06-02open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueB
GrowthC-
ProfitabilityF
Financial healthC+
MomentumC+
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
15.7952-week36.19
Revenue
$738M
+24.4% YoY
Net margin
-17.8%
ROE
-21.0%
P/E
—

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$738M+24.4%
Net income-$131M-26.6%
Gross profit$496M+20.8%
Operating income-$145M-18.5%
Diluted EPS-$1.22-19.6%
Cash & equivalents$124M+49.7%
Total assets$1.11B+27.9%
Total liabilities$490M+23.6%
Stockholders' equity$624M+31.4%
Gross: 67.1%Op.: -19.6%L/E: 0.78x

Frequently asked

Is Braze, Inc. (BRZE) a buy?
BRZE currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Cheap at 3.2x sales while cash flow inflects hard — 24% grower whose GAAP losses mask a real FCF turn.
What is Braze, Inc.'s quality score?
BRZE scores 51.50941471009005/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001676238, latest 10-Q filed 2026-05-28) · EODHD · Proprietary analysis · as of 6/30/2026, 4:02:33 AM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-30
Wassenaar Yvonne
Director
Award7.75K
2026-06-30
Levy Tara Walpert
Director
Award7.75K
2026-06-30
OBSTLER DAVID M
Director
Award7.75K
2026-06-30
FERNANDEZ PHILLIP M
Director
Award7.75K
2026-06-30
Machado Fernando
Director
Award7.75K
2026-06-30
Agrawal Neeraj
Director
Award7.75K
2026-06-24
Hyman Jonathan
Chief Technology Officer
Gift500K
2026-06-24
Hyman Jonathan
Chief Technology Officer
Gift150K
2026-06-24
Hyman Jonathan
Chief Technology Officer
Gift350K
2026-06-05
Agrawal Neeraj
Director
Gift500K

Earnings history

beat/miss · move
2026-05-27Miss -28.8% est▼ -3.42%8-K ↗
2026-03-24Miss -5.1% est▼ -4.76%8-K ↗
2025-12-09Beat +391.8% est▲ +2.06%8-K ↗
2025-09-04—▲ +2.48%8-K ↗
2025-06-05—▼ -1.39%8-K ↗
2025-03-27—▼ -1.69%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
2 Cash-Producing Stocks to Target This Week and 1 We AvoidBullish
finance.yahoo.com· 2026-07-03
MongoDB, Paylocity, and Braze Shares Are Soaring, What You Need To KnowBullish
finance.yahoo.com· 2026-07-01
Braze (BRZE) is One of the Best Tech Stocks to Buy for the Next 5 YearsBullish
finance.yahoo.com· 2026-07-01
Goldman Sachs Says These 2 Software Stocks Could Surge at Least 60% From Current LevelsBullish
finance.yahoo.com· 2026-06-28
Braze Inc. (BRZE) is One of the Worst AI Stocks Under $30, As Per Short SellersBullish
finance.yahoo.com· 2026-06-28
Why Braze Stock Jumped TodayBearish
finance.yahoo.com· 2026-06-26

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score52 vs 67
Revenue growth24.4% vs 7.5%
Net margin-17.8% vs 10.0%
Return on equity-21.0% vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 28d
Bullish
+0.05
vs typical · 59 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.